BioNexus Gene Lab Corp


BioNexus Gene Lab Corp

  • Price (USD)2.50
  • Today's Change1.23 / 96.85%
  • Shares traded620.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Dec 04 2020 14:53 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • BGLC:QBB price moved over -54.55% to 1.25
  • BGLC:QBB trading volume exceeds daily average by +534.12%
  • BGLC:QBB price rises above 15-day moving average to 2.50 at 09:53 GMT
  • BGLC:QBB price falls below 15-day moving average to 1.25 at 15:01 GMT

Key statistics

On Friday, BioNexus Gene Lab Corp (BGLC:QBB) closed at 2.50, -27.54% below its 52-week high of 3.45, set on Oct 21, 2020.
52-week range
0.36Sep 16 20203.45Oct 21 2020
Previous close1.27
Average volume1.12k
Shares outstanding102.73m
Free float35.73m
P/E (TTM)--
Market cap256.83m USD
EPS (TTM)-0.0028
Data delayed at least 15 minutes, as of Dec 04 2020 14:53 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.